B. Metzler seel. Sohn & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.9M | Buy |
98,227
+3,367
| +4% | +$373K | 0.1% | 100 |
|
2025
Q1 | $10.6M | Buy |
94,860
+12,265
| +15% | +$1.37M | 0.11% | 96 |
|
2024
Q4 | $7.63M | Sell |
82,595
-30,906
| -27% | -$2.85M | 0.08% | 117 |
|
2024
Q3 | $9.52M | Sell |
113,501
-2,476
| -2% | -$208K | 0.09% | 117 |
|
2024
Q2 | $7.96M | Sell |
115,977
-1,167
| -1% | -$80.1K | 0.08% | 124 |
|
2024
Q1 | $8.58M | Buy |
117,144
+6,683
| +6% | +$490K | 0.09% | 117 |
|
2023
Q4 | $8.95M | Sell |
110,461
-3,303
| -3% | -$268K | 0.11% | 104 |
|
2023
Q3 | $8.52M | Buy |
113,764
+20,670
| +22% | +$1.55M | 0.13% | 99 |
|
2023
Q2 | $7.17M | Buy |
93,094
+1,425
| +2% | +$110K | 0.1% | 142 |
|
2023
Q1 | $7.61M | Sell |
91,669
-12,892
| -12% | -$1.07M | 0.12% | 118 |
|
2022
Q4 | $8.98M | Sell |
104,561
-21,057
| -17% | -$1.81M | 0.15% | 103 |
|
2022
Q3 | $7.75M | Buy |
125,618
+17,816
| +17% | +$1.1M | 0.14% | 108 |
|
2022
Q2 | $6.66M | Sell |
107,802
-25,464
| -19% | -$1.57M | 0.11% | 131 |
|
2022
Q1 | $7.92M | Buy |
133,266
+12,266
| +10% | +$729K | 0.11% | 132 |
|
2021
Q4 | $8.88M | Buy |
121,000
+50,955
| +73% | +$3.74M | 0.12% | 121 |
|
2021
Q3 | $4.89M | Buy |
70,045
+5,791
| +9% | +$404K | 0.07% | 167 |
|
2021
Q2 | $4.43M | Sell |
64,254
-19,996
| -24% | -$1.38M | 0.07% | 163 |
|
2021
Q1 | $5.44M | Sell |
84,250
-6,487
| -7% | -$419K | 0.09% | 144 |
|
2020
Q4 | $5.37M | Buy |
+90,737
| New | +$5.37M | 0.1% | 130 |
|